« Back to Malignant Tumors of the Skin

Malignant Melanoma

»What is melanoma?
»How common is malignant melanoma in the United States?
»What causes melanoma?
»What groups have a genetic predisposition to familial melanoma?
»List the risk factors for melanoma.
»List the high-risk groups for developing melanoma.
»Do all melanomas develop from atypical nevi?
»What are cancer stem cells?
»Is melanoma a single disease?
»What are the molecular pathways in melanoma?
»Is there a host immune response to melanoma?
»Describe the clinical appearance of melanoma.
»What are the ABCDEs of melanoma?
»What is dermoscopy?
»Where on the body does melanoma most commonly arise?
»Are there different types of melanoma?
»What are Clark’s levels?
»What is Breslow’s depth?
»What other findings should be reported in the histopathologic diagnosis of melanoma?
»What are the common immunohistochemical (IHC) markers utilized in the diagnosis of melanoma?
»Are there other factors with prognostic impact in patients with melanoma?
»How are patients with melanoma evaluated after the initial diagnosis?
»What is the most current system for staging melanoma?
»How is melanoma treated?
»How wide should surgical margins be?
»What is the most important risk factor for local recurrence of primary melanoma?
»Does a biopsy of melanoma increase the risk of spreading tumor cells or causing metastases?
»Describe the recommended follow-up for a patient with melanoma.
»Which tests or examinations are conducted during the routine follow-up of patients who have had melanoma?
»Does local tumor recurrence influence overall survival?
»What is elective lymph node dissection (ELND)? When is it indicated?
»What is sentinel lymph node biopsy? When is it indicated?
»What is linear melanonychia?
»What is Hutchinson’s sign?
»What is Hutchinson’s freckle?
»Are there any new ways to assess prognosis in patients with melanoma?
»What forms of chemotherapy are used in the treatment of metastatic melanoma?
»Is radiation therapy effective for melanoma?
»How effective is immunotherapy in malignant melanoma?
»Does gene therapy offer any better results?
»How about local perfusion?
»What are some newer targeted therapies for melanoma?

 
 
 

List the risk factors for melanoma.

Risk factors for malignant melanoma may be divided into genetic factors, environmental factors, and the interaction between the two.

Genetic factors include past medical history of melanoma, familial medical history of melanoma in a first-degree relative, Fitzpatrick type I or II skin, large congential nevi, the presence of dysplastic (atypical) nevi, >50 benign nevi (>2 mm in size), xeroderma pigmentosum, and familial dysplastic mole syndrome (FDMS). In FDMS, which is defined as occurring in families with atypical nevi and two or more blood relatives with melanoma, the estimated prevalence of melanoma approaches 85% by age 48. It is noteworthy that variations in the melanocortin receptor 1 (MCR1) gene, which is a component of pigment diversity, also confer an increased risk of melanoma. Variants differ in their associations with melanoma and nonmelanoma skin cancer, but both red hair and non–red hair variants confer increased risk.


Environmental factors include intermittently high-intensity exposure of fair skin to UVA and UVB radiation (especially at a young age), sunburns, immune suppression, and residence in equatorial latitudes. Ephelides (freckles), which are a reflection of sun exposure, are associated with a two- to threefold increased risk of melanoma.

MacKie RM, Hauschild A, Eggermont AM: Epidemiology of invasive cutaneous melanoma, Ann Oncol 20(Suppl 6):vi1–vi7, 2009.